{"filing":{"accession_number":"0001493152-26-026431","cik":"0001873835","ticker":"IMMX","company_name":"Immix Biopharma, Inc.","form":"8-K","filing_date":"2026-05-29","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315226026431/form8-k.htm"},"events":[{"id":8220,"run_id":7211,"accession_number":"0001493152-26-026431","anchor_item_number":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"The 8-K discloses Item 5.07 results from the May 22, 2026 Annual Meeting of stockholders, reporting voting outcomes on two proposals: (1) election of nine directors with detailed vote tallies (For/Withheld/Broker Non-Votes), and (2) ratification of Crowe LLP as independent auditor. This is a textbook shareholder vote results disclosure, material to investors as it confirms board composition and auditor appointment.","company_name":"Immix Biopharma, Inc.","ticker":"IMMX","filing_date":"2026-05-29","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":2849,"accession_number":"0001493152-26-026431","item_number":null,"item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"The 8-K discloses Item 5.07 results from the May 22, 2026 Annual Meeting of stockholders, reporting voting outcomes on two proposals: (1) election of nine directors with detailed vote tallies (For/Withheld/Broker Non-Votes), and (2) ratification of Crowe LLP as independent auditor. This is a textbook shareholder vote results disclosure, material to investors as it confirms board composition and auditor appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:37:25.627936+00:00","company_name":"Immix Biopharma, Inc.","ticker":"IMMX","filing_date":"2026-05-29"}]}